EUVIMEDEUVIMED entdecken
Crossref

INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema

Naiem T Issa, JiaDe Yu, Christopher G Bunick, Leon Kircik

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.025412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Naiem T Issa und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Eczema, Hand Dermatoses, Janus Kinase Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatologic AgentsEczemaHand DermatosesJanus Kinase InhibitorsHumansChronic DiseaseClinical Trials, Phase III as TopicQuality of LifeSkin CreamTreatment OutcomePyrroles

Substanzen

delgocitinibDermatologic AgentsJanus Kinase InhibitorsPyrroles

Zitieren

APA

Issa, N. T., Yu, J., Bunick, C. G., & Kircik, L. (2025). INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.025412

Vancouver

Issa NT, Yu J, Bunick CG, Kircik L. INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.025412

BibTeX
@article{Issa2025,
  author = {Issa, Naiem T and Yu, JiaDe and Bunick, Christopher G and Kircik, Leon},
  title = {INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.025412}
}
Kostenlos starten →